LYMPHOID NEOPLASIA Telomere length in mantle cell lymphoma

[1]  H. Kestler,et al.  Transient telomere dysfunction induces chromosomal instability and promotes carcinogenesis. , 2012, The Journal of clinical investigation.

[2]  L. Bonaldi,et al.  Telomere length and telomerase levels delineate subgroups of B-cell chronic lymphocytic leukemia with different biological characteristics and clinical outcomes , 2012, Haematologica.

[3]  Ryan D. Morin,et al.  Whole transcriptome sequencing reveals recurrent NOTCH1 mutations in mantle cell lymphoma. , 2012, Blood.

[4]  A. Rosenwald,et al.  Is there a role for antigen selection in mantle cell lymphoma? Immunogenetic support from a series of 807 cases. , 2011, Blood.

[5]  L. Staudt,et al.  Pathway discovery in mantle cell lymphoma by integrated analysis of high-resolution gene expression and copy number profiling. , 2010, Blood.

[6]  A. Rosenwald,et al.  Genomic and gene expression profiling defines indolent forms of mantle cell lymphoma. , 2010, Cancer research.

[7]  M. Narbaitz,et al.  Analysis of telomere length in mantle cell lymphoma , 2009, European journal of haematology.

[8]  Michael Hallek,et al.  Detailed analysis of p53 pathway defects in fludarabine-refractory chronic lymphocytic leukemia (CLL): dissecting the contribution of 17p deletion, TP53 mutation, p53-p21 dysfunction, and miR34a in a prospective clinical trial. , 2009, Blood.

[9]  E. Hoster,et al.  Improvement of overall survival in advanced stage mantle cell lymphoma. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[10]  Philip Thomas,et al.  A quantitative real-time PCR method for absolute telomere length. , 2008, BioTechniques.

[11]  H. Müller-Hermelink,et al.  Genomic aberrations in mantle cell lymphoma detected by interphase fluorescence in situ hybridization. Incidence and clinicopathological correlations , 2008, Haematologica.

[12]  H. Döhner,et al.  Short telomeres are associated with genetic complexity, high-risk genomic aberrations, and short survival in chronic lymphocytic leukemia. , 2008, Blood.

[13]  Martin Dreyling,et al.  A new prognostic index (MIPI) for patients with advanced-stage mantle cell lymphoma. , 2006, Blood.

[14]  Adrian Wiestner,et al.  Point mutations and genomic deletions in CCND1 create stable truncated cyclin D1 mRNAs that are associated with increased proliferation rate and shorter survival. , 2007, Blood.

[15]  R. Rosenquist,et al.  Telomere length and correlation with histopathogenesis in B‐cell leukemias/lymphomas , 2007, European journal of haematology.

[16]  A. Rosenwald,et al.  The Ki67 proliferation index is a quantitative indicator of clinical risk in mantle cell lymphoma. , 2006, Blood.

[17]  G. Ott,et al.  Genomic DNA-chip hybridization in t(11;14)-positive mantle cell lymphomas shows a high frequency of aberrations and allows a refined characterization of consensus regions. , 2004, Blood.

[18]  M. Boccadoro,et al.  Telomere length correlates with histopathogenesis according to the germinal center in mature B-cell lymphoproliferative disorders. , 2004, Blood.

[19]  P. Gregersen,et al.  Telomere length and telomerase activity delineate distinctive replicative features of the B-CLL subgroups defined by immunoglobulin V gene mutations. , 2004, Blood.

[20]  H. Müller-Hermelink,et al.  VH mutation status and VDJ rearrangement structure in mantle cell lymphoma: correlation with genomic aberrations, clinical characteristics, and outcome. , 2003, Blood.

[21]  L. Staudt,et al.  The proliferation gene expression signature is a quantitative integrator of oncogenic events that predicts survival in mantle cell lymphoma. , 2003, Cancer cell.

[22]  R. Cawthon.  Telomere measurement by quantitative PCR. , 2002, Nucleic acids research.

[23]  H. Döhner,et al.  Mantle cell lymphoma is characterized by inactivation of the ATM gene. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[24]  F. Bosch,et al.  p53 gene mutations and protein overexpression are associated with aggressive variants of mantle cell lymphomas. , 1996, Blood.

[25]  P. Kruk,et al.  DNA damage and repair in telomeres: relation to aging. , 1995, Proceedings of the National Academy of Sciences of the United States of America.